SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-035289
Filing Date
2020-08-03
Accepted
2020-08-03 07:00:43
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20200630.htm   iXBRL 10-Q 1420714
2 EX-10.2 nerv-ex102_120.htm EX-10.2 41082
3 EX-10.3 nerv-ex103_210.htm EX-10.3 233292
4 EX-31.1 nerv-ex311_7.htm EX-31.1 17378
5 EX-31.2 nerv-ex312_6.htm EX-31.2 16688
6 EX-32.1 nerv-ex321_8.htm EX-32.1 9446
  Complete submission text file 0001564590-20-035289.txt   6616551

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA nerv-20200630.xsd EX-101.SCH 39267
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20200630_cal.xml EX-101.CAL 40278
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20200630_def.xml EX-101.DEF 158710
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20200630_lab.xml EX-101.LAB 357176
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20200630_pre.xml EX-101.PRE 286700
12 EXTRACTED XBRL INSTANCE DOCUMENT nerv-10q_20200630_htm.xml XML 1292716
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 201067786
SIC: 2834 Pharmaceutical Preparations